Log In
Print
BCIQ
Print
Print this Print this
 

Ularitide (ULA01)

  Manage Alerts
Collapse Summary General Information
Company Cardiorentis AG
DescriptionIV infusion of a chemically synthesized form of the naturally occurring natriuretic peptide urodilatin
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase III
Standard IndicationHeart failure
Indication DetailsTreat acute decompensated heart failure (ADHF); Treat acute heart failure (AHF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today